{"entity":{"id":"nct03228277","kind":"trial","name":"Olmutinib Trial in T790M (+) NSCLC Patients Detected by Liquid Biopsy Using BALF Extracellular Vesicular DNA","aka":[],"tldr":"A phase 2 trial of Olmutinib in Non-small-cell lung cancer, run by Konkuk University Medical Center, completed.","summary":"Olmutinib Trial in T790M (+) NSCLC Patients Detected by Liquid Biopsy Using BALF Extracellular Vesicular DNA is a phase 2 interventional study registered as NCT03228277 by Konkuk University Medical Center, with 25 participants recorded, started 2017-07-17 and reaching its primary completion in 2018-07-31. Interventions recorded: Olmutinib. Conditions recorded: Non Small Cell Lung Cancer.\n\nLinked to the drug Olmutinib because the registry names it among its interventions and Non-small-cell lung cancer among its conditions. Registry record only: no result has been read by an editor.","status":"completed","asOf":"2026-09-22","links":[{"label":"ClinicalTrials.gov NCT03228277","url":"https://clinicaltrials.gov/study/NCT03228277"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["nsclc"],"sections":[],"technologies":[],"targets":[],"drugs":["olmutinib"],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT03228277","phase":"2","setting":"Phase II, Multicenter, Single-arm, Open-label Study to Evaluate the Efficacy of Olmutinib(Olita®) in Patients With NSCLC Who Harboring T790M Mutation Confirmed Using DNA Extracted From Extracellular Vesicles in Bronchoalveolar Lavage Fluid","sponsor":"Konkuk University Medical Center","enrolled":25,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct03228277/","neighbours":{"cancer":[{"id":"nsclc","kind":"cancer","name":"Non-small-cell lung cancer","route":"/cancers/nsclc/"}],"drug":[{"id":"olmutinib","kind":"drug","name":"Olmutinib","route":"/drugs/olmutinib/"}]}}